Safety depends entirely on supplier quality and user diligence
Semaglutide is Novo Nordisk's FDA-approved GLP-1 receptor agonist , sold as Ozempic (for type 2 diabetes) and Wegovy (for weight loss)
Narrator: Christine lost 150 pounds through diet and sheer will power
Tirzepatide: The Dual Agonist Tirzepatide is often referred to as the next generation GLP-1 because it targets two hormones : This dual mechanism seems to amplify its effects
Fast service already down 10 lbs in 1 month Its really helping me with cravings Reaching my goals much quicker So far, so good
As Hemmi notes: Some people will lose access. In an emailed statement to WIRED, a spokesperson for Novo Nordisk says, Moving forward, any compounder that mass produces or sells knockoff drugs is breaking the law and compromising patient safety. A spokesperson for Eli Lilly echoed that sentiment, saying via email that the FDA and a federal court have both made clear that compounders must cease production of compounded tirzepatide knockoffs. Anthony Comuzzie, CEO of the Obesity Society, recognizes that there are legitimate access issues to GLP-1 medications, but he worries that some people who have sought out compounded versions may not meet the medical definition of obesity and are using them more casually for weight loss
